April 25th, 2025 |
Brian Slingsby |
Director, 10 Percent Owner: |
Purchase
|
259.26K |
$3.50M |
8.90M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
259259 |
$13.50 |
$3.50M |
|
April 15th, 2025 |
David Rodman |
Chief Medical Officer |
Exercise Sale
|
24.06K |
$178.90K |
123.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Common Stock |
Sale
|
2966 |
$13.69 |
$40.61K |
Common Stock |
Sale
|
8400 |
$14.83 |
$124.57K |
Stock Option |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
|
April 15th, 2025 |
Adam Levy |
CFO And Secretary |
Sale
|
10.76K |
$129.68K |
215.34K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10757 |
$12.06 |
$129.68K |
|
April 15th, 2025 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
15.32K |
$186.80K |
862.29K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15319 |
$12.19 |
$186.80K |
|
April 3rd, 2025 |
David Rodman |
Chief Medical Officer |
Exercise Sale
|
58.98K |
$882.48K |
172.47K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
1606 |
$1.08 |
$1.73K |
Common Stock |
Sale
|
30574 |
$15.00 |
$458.54K |
Common Stock |
Sale
|
2791 |
$16.02 |
$44.72K |
Common Stock |
Sale
|
22406 |
$16.77 |
$375.75K |
Stock Option |
Exercise/Conversion
|
1606 |
$1.08 |
$1.73K |
|
March 17th, 2025 |
Llc Samsara biocapital gp |
10 Percent Owner |
Purchase
|
600.00K |
$8.10M |
5.67M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
600000 |
$13.50 |
$8.10M |
|
March 17th, 2025 |
Srinivas Akkaraju |
Director |
Purchase
|
600.00K |
$8.10M |
5.67M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
600000 |
$13.50 |
$8.10M |
|
March 17th, 2025 |
L.p. Ra capital management |
Director |
Purchase
|
1.30M |
$17.50M |
4.28M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
1296296 |
$13.50 |
$17.50M |
|
March 13th, 2025 |
David Rodman |
Chief Medical Officer |
Exercise
|
12.70K |
$13.71K |
170.87K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Stock Option |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
|
February 24th, 2025 |
L.p. Ra capital management |
Director |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Adam Levy |
CFO And Secretary |
Stock Award
|
170.00K |
$1.73M |
170.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
170000 |
$10.20 |
$1.73M |
|
February 24th, 2025 |
David Rodman |
Chief Medical Officer |
Stock Award
|
170.00K |
$1.73M |
170.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
170000 |
$10.20 |
$1.73M |
|
February 24th, 2025 |
Srinivas Akkaraju |
Director, 10 Percent Owner: |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Brian Slingsby |
Director, 10 Percent Owner: |
Stock Award Other
|
98.70K |
$1.01M |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
Stock Option |
Other
|
32900 |
$10.20 |
$335.58K |
Stock Option |
Other
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Derek Dirocco |
Director |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Alexander Gold |
Director |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Stock Award
|
570.00K |
$5.81M |
570.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
570000 |
$10.20 |
$5.81M |
|
February 24th, 2025 |
Daphne Karydas |
Director |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 24th, 2025 |
Glenn Sblendorio |
Director |
Stock Award
|
32.90K |
$335.58K |
32.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
32900 |
$10.20 |
$335.58K |
|
February 13th, 2025 |
David Rodman |
Chief Medical Officer |
Exercise
|
12.70K |
$13.71K |
164.52K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Stock Option |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
|
January 15th, 2025 |
Adam Levy |
CFO And Secretary |
Sale
|
10.76K |
$97.86K |
226.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10657 |
$9.09 |
$96.90K |
Common Stock |
Sale
|
100 |
$9.63 |
$963 |
|
January 15th, 2025 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
158.17K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Stock Option |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
|
January 15th, 2025 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
18.33K |
$166.08K |
877.61K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
18333 |
$9.06 |
$166.08K |
|
January 7th, 2025 |
Brian Slingsby |
Director, 10 Percent Owner: |
Other
|
44.00K |
$550.88K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Other
|
22000 |
$12.52 |
$275.44K |
Stock Option |
Other
|
22000 |
$12.52 |
$275.44K |
|
December 13th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
10.03K |
$5.42K |
146.01K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
November 12th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise Sale
|
25.11K |
$91.67K |
146.02K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5026 |
$1.08 |
$5.43K |
Common Stock |
Sale
|
5026 |
$15.00 |
$75.40K |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5026 |
$1.08 |
$5.43K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
November 8th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise Sale
|
76.45K |
$438.11K |
161.46K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
25482 |
$1.08 |
$27.52K |
Stock Option |
Exercise/Conversion
|
25482 |
$1.08 |
$27.52K |
Common Stock |
Sale
|
25482 |
$15.03 |
$383.07K |
|
October 15th, 2024 |
Adam Levy |
CFO And Secretary |
Sale
|
10.76K |
$146.00K |
236.85K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10757 |
$13.57 |
$146.00K |
|
October 15th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
20.74K |
$16.98K |
165.43K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
5352 |
$1.08 |
$5.78K |
Common Stock |
Exercise/Conversion
|
5352 |
$1.08 |
$5.78K |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
October 15th, 2024 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
15.27K |
$206.43K |
895.94K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15271 |
$13.52 |
$206.43K |
|
September 12th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
170.79K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
|
August 13th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
177.13K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
July 26th, 2024 |
Brian Slingsby |
Director, 10 Percent Owner: |
Sale
|
550.00K |
$7.18M |
8.64M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
550000 |
$13.05 |
$7.18M |
|
July 18th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise Sale
|
1.57K |
$9.01K |
183.48K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
525 |
$1.08 |
$567 |
Common Stock |
Exercise/Conversion
|
525 |
$1.08 |
$567 |
Common Stock |
Sale
|
525 |
$15.00 |
$7.88K |
|
July 12th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
184.01K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
July 12th, 2024 |
Adam Levy |
CFO And Secretary |
Sale
|
10.76K |
$141.39K |
247.61K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10757 |
$13.14 |
$141.39K |
|
July 12th, 2024 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
15.75K |
$210.08K |
911.21K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15746 |
$13.34 |
$210.08K |
|
June 20th, 2024 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
49.31K |
$592.02K |
958.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17766 |
$12.25 |
$217.71K |
Common Stock |
Sale
|
16607 |
$11.99 |
$199.07K |
Common Stock |
Sale
|
14940 |
$11.73 |
$175.24K |
|
June 17th, 2024 |
Alexander Gold |
Director |
Stock Award
|
44.00K |
$558.36K |
44.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
44000 |
$12.69 |
$558.36K |
|
June 17th, 2024 |
Alexander Gold |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
June 14th, 2024 |
Jon Congleton |
Director, Officer: Chief Executive Officer |
Sale
|
72.80K |
$924.20K |
1.03M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
16607 |
$12.77 |
$212.01K |
Common Stock |
Sale
|
39961 |
$12.74 |
$509.03K |
Common Stock |
Sale
|
16229 |
$12.52 |
$203.16K |
|
June 13th, 2024 |
Adam Levy |
CFO And Secretary |
Sale
|
96.81K |
$1.25M |
255.46K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
96815 |
$12.94 |
$1.25M |
|
June 13th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
190.36K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
6349 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5017 |
$0.54 |
$2.71K |
|
May 28th, 2024 |
L.p. Ra capital management |
Director |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Derek Dirocco |
Director |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Glenn Sblendorio |
Director |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Srinivas Akkaraju |
Director, 10 Percent Owner: |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Daphne Karydas |
Director |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Brian Slingsby |
Director, 10 Percent Owner: |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 23rd, 2024 |
Olivier Litzka |
Director |
Stock Award
|
22.00K |
$275.44K |
22.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Stock Award
|
22000 |
$12.52 |
$275.44K |
|
May 15th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
22.73K |
$19.13K |
196.71K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
6348 |
$1.08 |
$6.86K |
Common Stock |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
Stock Option |
Exercise/Conversion
|
5018 |
$0.54 |
$2.71K |
|
May 10th, 2024 |
David Rodman |
Chief Medical Officer |
Exercise
|
200 |
$216 |
203.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option |
Exercise/Conversion
|
100 |
$1.08 |
$108 |
Common Stock |
Exercise/Conversion
|
100 |
$1.08 |
$108 |
|